News

Recently, Mycoplasma pneumoniae has been highly prevalent. Since there is currently no available vaccine for Mycoplasma pneumoniae, it is important to develop good disease management habits to prevent infection. Here are some tips:

The accurate and timely detection of respiratory tract infections plays a crucial role in public health management. These infections, caused by various pathogens such as viruses and bacteria, can range from mild colds to severe respiratory illnesses.

Mycoplasma pneumoniae is an atypical pathogen. It is neither a virus nor a bacterium, but a microorganism intermediate in size between a bacterium and a virus.

The clinical application of a rapid detection for influenza A and B viruses, with the colloidal gold method, holds a significant importance in healthcare. Influenza viruses, especially types A and B, are responsible for seasonal outbreaks and can cause severe respiratory illnesses.

Mycoplasma pneumoniae, a microorganism that is distinct from bacteria, its size is between bacteria and viruses, and it arouses mycoplasma pneumoniae infection when it enters the human body.

The clinical application of the colloidal gold method rapid detection program for mycoplasma pneumonia infections holds significant importance in the field of healthcare.

WIZ's two reagents, HBA1C assay kits (fluorescent immunochromatography) and the SARS-CoV-2 Antigen Rapid Test (Colloidal gold) (Anterior nasal) have been approved by the Medical Device Authority (MDA) of Malaysia and began market access.

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has announced that 66 WIZ products have received UKCA certification. It means that WIZ products are officially certified for quality and safety, and can be legally sold and used in the UK and other countries and territories that recognize the UK UKCA registration.

December 20th, 2022, Wizbiotech Glycosylated Hemoglobin A1c and 25-hydroxy Vitamin D test kit obtain UKCA registration, which marks the possiblity to enpower British health management.

Recently, the new coronavirus (2019-nCoV) antigen detection kit (Colloidal gold method) developed by Xiamen Wiz Biotech Co., Ltd. has been approved by the National Medical Products Administration.

Recently, the portable immune analyzer WIZ-A101 from Wizbiotech has obtained the IVDR CE certification.

According to the latest HSC Common List published on October 17, 2022, the SARS-CoV-2 Antigen Rapid Test produced by Wizbiotech has been listed in HSC Common List Class A.

From July 25 to 27, 2023, WIZ attended the AACC, American Clinical Chemistry Annual Meeting and International Clinical Trial Exhibition held in Anaheim, California, USA, attracting many professionals viewing and asking.

16th November 2023, the 55th MEDICA trade fair came to a successful end in Dusseldorf, Germany.

On 13th November, 2023, MEDICA, the summit event of the medical industry, was grandly opened in Dusseldorf, Germany.

October 17-19, 2023, the 11th South African International Medical Device Exhibition was opened grandly in Gallagher Convention Centre.

From September 26 to 28, 2023, the 3-day Medic West Africa came to an end! We would like to thank the excellent team of Wizbiotech for coming to Nigeria and the customers and partners from all the countries in the world for coming to this exhibition. We are very honored and your participation had added more joy and motivation to us.

From September 13 to 15, the 3-day 2023 Medic East Africa was successfully concluded at Kenyatta International Convention Center in Kenya! Wizbiotech, as a POCT company with "integrated production, marketing, and research", joined hands with immunofluorescence solutions and infectious disease solutions at the exhibition, a panoramic display of Wizbiotech's research and development achievements in the health industry.